/rss/research-newsFind news related to research at Mayo Clinic.en-USPHOENIX — Researchers at Mayo Clinic, in collaboration with the Terasaki Institute for Biomedical Innovation, have developed a real-time monitoring system designed to give transplant teams a more complete picture of a donor liver's health during machine perfusion. Published in Nature Communications, the study represents an important step toward more accurate evaluation of donor livers, laying the groundwork for future advances in organ preservation and transplantation. During machine perfusion, a donor liver is connected to…https://newsnetwork.mayoclinic.org/?p=416548Tuesday, July 14, 2026Mayo Clinic researchers are uncovering the earliest shifts in disease biology — long before symptoms appear — revealing how disease takes root and opening new possibilities to change its course.  By the time a disease is diagnosed, it may have been developing silently for years. Along the way, the body leaves clues: proteins shift, metabolism changes, immune responses evolve, and environmental exposures leave measurable traces. Until recently, many of these early signals were impossible to detect. Mayo Clinic…https://newsnetwork.mayoclinic.org/?p=416365Thursday, July 9, 2026A novel theranostics study explores imaging- and data-informed approaches to support individualized treatment decisions and expand access to theranostics Collaboration stems from a 2023 Strategic Radiology Research Alliance between Mayo Clinic and GE HealthCare, aimed at transforming the experience of patients and clinicians in the practice of radiology and the delivery of novel therapies CHICAGO, Ill. and ROCHESTER, Minn. — GE HealthCare and Mayo Clinic today announced the MI-BET (Molecular Imaging Biomarker-Based End of Therapy…https://newsnetwork.mayoclinic.org/?p=416368Wednesday, July 8, 2026ROCHESTER, Minn. — Researchers have validated a genetic scoring tool that may help physicians diagnose idiopathic pulmonary fibrosis and identify which patients are at greatest risk for severe outcomes, including death or the need for a lung transplant. The findings come from a new international study of more than 570,000 people co-led by Mayo Clinic and Brigham and Women's Hospital. Published in the American Journal of Respiratory and Critical Care Medicine, the study is one…https://newsnetwork.mayoclinic.org/?p=416383Tuesday, July 7, 2026A new Mayo Clinic study shows that integrating telomere length evaluation and genetic testing into pulmonary care can significantly change how physicians diagnose and treat pulmonary fibrosis — in some cases even redirecting the course of care.https://newsnetwork.mayoclinic.org/?p=413598Thursday, July 2, 2026Dr. Nick Gregg, neurologist, and Dr. Dora Hermes Miller, biomedical engineer, look at brain imaging on a computer in the Multimodal Neuroimaging lab. ROCHESTER, Minn. — Mayo Clinic researchers have created a detailed map of the pulvinar, a deep brain region that could help doctors more precisely target brain stimulation therapies for people with drug-resistant epilepsy. The findings, published in the Journal of Neuroscience, reveal that brain regions separated by only a few millimeters connect…https://newsnetwork.mayoclinic.org/?p=416289Wednesday, July 1, 2026Christina Chen, M.D., a Mayo Clinic physician in internal medicine and geriatrics, is working to change how clinicians and patients think about aging. In a publication in Mayo Clinic Proceedings, coauthored with Sara Bonnes, M.D., she outlines a new framework for "healthspan" — the years of life spent in good health, with preserved function, cognition and independence. Here, Dr. Chen explains why living longer is not the same as living well, and how that distinction could reshape medical care.https://newsnetwork.mayoclinic.org/?p=413703Wednesday, July 1, 2026This episode of "Tomorrow's Cure" features Oana Dumitrascu, M.D., a vascular neurologist at Mayo Clinic in Arizona, and Yalin Wang, Ph.D., program chair of the Computer Science Graduate Programs in the School of Computing and Augmented Intelligence at Arizona State University, as they discuss a new, noninvasive approach to learning more about Alzheimer's disease. The episode explores how researchers are using artificial intelligence (AI) and routine eye scans to look for early signs of Alzheimer's…https://newsnetwork.mayoclinic.org/?p=416266Wednesday, July 1, 2026Mayo Clinic’s Berg Innovation Exchange and Business Development unite expertise in collaboration, commercialization and venture creation to accelerate innovation worldwide ROCHESTER, Minn. — Mayo Clinic is strengthening its commitment to advancing healthcare innovation by aligning the Mayo Clinic Berg Innovation Exchange with Mayo Clinic Business Development, creating new opportunities to help promising discoveries reach patients and communities worldwide. Since its launch, the Berg Innovation Exchange has connected innovators with expertise, mentorship and a global network…https://newsnetwork.mayoclinic.org/?p=416251Tuesday, June 30, 2026Shutterstock ROCHESTER, Minn. — Researchers at Mayo Clinic have uncovered a previously hidden step in how the immune system prepares to fight cancer, a discovery that could help scientists develop more effective and longer-lasting cancer immunotherapies. Published in Nature Communications, the study found that some cancer-fighting immune cells begin preparing for their role much earlier than previously believed — while they are still maturing in the thymus, an organ behind the breastbone that plays a…https://newsnetwork.mayoclinic.org/?p=416088Wednesday, June 24, 2026Getty Study uncovers structure of protein that helps cells communicate, a potential drug target ROCHESTER, Minn. — After nearly four decades of research, Mayo Clinic scientists have revealed the molecular structures of protein kinase C beta (PKCβ), a key protein linked to cancer and neurological diseases. The findings, published in Nature Communications, provide the first detailed view of how the protein works and how the breast cancer drug endoxifen can target this protein. PKCs are…https://newsnetwork.mayoclinic.org/?p=416084Tuesday, June 23, 2026At Mayo Clinic, neuroscientists are seeking to understand — and ultimately restore — brain function through advanced computational tools, neuromodulation technologies and multidisciplinary collaboration. Gelareh Zadeh, M.D., Ph.D. These new efforts are led by Gelareh Zadeh, M.D., Ph.D., a neurosurgeon and scientist. Dr. Zadeh specializes in neuro-oncology and has clinical expertise in treating brain tumors such as gliomas and meningiomas. Her research focuses on the molecular and genomic landscape of these tumors to advance precision…https://newsnetwork.mayoclinic.org/?p=416056Monday, June 22, 2026The BAC on routine screening mammograms is shown in red. AI was used to help clinicians measure and quantify it, creating an opportunity to assess heart disease risk during a test many women already receive without additional radiation or testing. A routine mammogram may do more than detect breast cancer, it also could help identify early signs of heart disease. Heart disease is the leading cause of death among women, responsible for 1 in 3…https://newsnetwork.mayoclinic.org/?p=416024Wednesday, June 17, 2026Mayo Clinic researchers have identified a previously unrecognized way the kidneys regulate water balance — an advance that could lead to improved treatments for polycystic kidney disease (PKD) and other disorders.https://newsnetwork.mayoclinic.org/?p=413549Tuesday, June 16, 2026One of the most detailed maps to date of meningioma — the most common brain tumor in adults — reveals how the tumor's surrounding environment helps drive disease behavior and patient outcomes, according to new research from Mayo Clinic.https://newsnetwork.mayoclinic.org/?p=415616Tuesday, June 9, 2026ROCHESTER, Minn. — Mayo Clinic researchers and collaborators have shown that an artificial intelligence (AI) tool can analyze routine pathology slides to help clinicians classify meningiomas, the most common primary brain tumor in adults, and better understand a patient’s risk of tumor recurrence. The study, published in The Lancet Digital Health, demonstrates that deep learning models can support the extraction of molecular and prognostic information from standard hematoxylin and eosin, or H&E, slides — the…https://newsnetwork.mayoclinic.org/?p=415769Monday, June 8, 2026PHOENIX — In a study published in the Liver Transplantation journal by the American Association for the Study of Liver Diseases, Mayo Clinic researchers found that a new proactive treatment protocol for alcohol use disorder after liver transplant resulted in a 0% heavy alcohol relapse rate among patients who followed the protocol, compared with a historical relapse rate of approximately 25%. "The results were greater than we expected," says Channa Jayasekera, M.D., Mayo Clinic transplant…https://newsnetwork.mayoclinic.org/?p=415735Wednesday, June 3, 2026PHOENIX — An experimental drug combination may help overcome treatment resistance in advanced kidney cancer, according to early results from a first-in-human clinical trial led by Mayo Clinic researchers. The study evaluated the investigational drug darlifarnib in combination with the targeted therapy cabozantinib, a standard treatment for clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer. Among patients whose disease had progressed despite prior treatment, 44% responded to the combination therapy,…https://newsnetwork.mayoclinic.org/?p=415648Tuesday, June 2, 2026Getty Images JACKSONVILLE, Fla. — Hormone therapy use among women in the U.S. remains low, even though it's an effective treatment for many menopause symptoms, according to a new Mayo Clinic study published in Mayo Clinic Proceedings. Menopause affects more than 1 million women each year in the U.S., and up to 75% experience symptoms such as hot flashes and night sweats that can last for years. Yet researchers found that use of menopausal hormone…https://newsnetwork.mayoclinic.org/?p=415627Monday, June 1, 2026Shutterstock ROCHESTER, Minn. — Mayo Clinic Comprehensive Cancer Center researchers will present more than 30 studies at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, highlighting advances in precision oncology, early cancer detection, artificial intelligence (AI) and personalized cancer care. The meeting will be held May 29–June 2 at the McCormick Place Convention Center in Chicago. Featured research includes biomarker-driven treatments for bladder and lung cancers, new approaches for triple-negative breast cancer, multicancer…https://newsnetwork.mayoclinic.org/?p=415387Wednesday, May 27, 2026